Hookipa Pharma Inc.
HOOKUnlisted companyHookipa Pharma Inc. in brief
Hookipa Pharma Inc. is an unlisted company in the Biotechnology industry, based in California, USA. It was founded in 2011. In its latest reported year it had sales of $20 M and a net loss of $44 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Hookipa Pharma Inc.
Hookipa Pharma is a Clinical Stage Biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. The company annual revenue is 19.6 million USD as on 2020. The headquarters is in USA.
Hookipa Pharma Inc. timeline
- 2011
- 🏁· approximateFounded
- 2019
- 🔔· approximateInitial public offering on Nasdaq
Events of Hookipa Pharma Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Hookipa Pharma Inc.
- Acquisitions and changes
- No longer listed: ticker HOOK is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #2,868 (Jan 2020) · #2,883 (Jan 2021) · #4,750 (Jan 2022) · #4,897 (Dec 2022) · #4,611 (Jul 2023) · #3,855 (Jan 2024)
Annual results
- Revenue
- $20 M
- Operating income
- —
- Net income
- $-44 M
Mutual funds holding Hookipa Pharma Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Large-Cap Growth PortfolioPacific Life Fund Advisors LLC | 8,859 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Guardian Large Cap Fundamental Growth VIP FundPark Avenue Institutional Advisers LLC | 2,270 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 AVIP Fidelity Institutional AM Equity Growth PortfolioCONSTELLATION INVESTMENTS INC | 679 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 3 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Markets and events: Hookipa Pharma Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-07-18 20:01 UTC, code T3, resumed 20:35 UTC
Fails to deliver
- : 95 shares at $1.15
- : 95 shares at $1.09
- : 99,995 shares at $0.84
- : 1,236 shares at $0.94
- : 62 shares at $1.48
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
How Hookipa Pharma Inc. compares in Biotechnology
- Revenue$20 M · higher than 50% of 647
- Net margin-225.6% · higher than 25% of 408
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hookipa Pharma Inc.🇺🇸 | $78 M | — | -225.6% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hookipa Pharma Inc.? Verify and update this profile — free
Show Hookipa Pharma Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.